Checkpoint Therapeutics, Inc. (CKPT) - Stock Prices, Stock Peers & Analysis

Home
CKPT

Company Name	Checkpoint Therapeutics, Inc.
Symbol	CKPT
Currency	USD
Price	4.26
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	367,723,200
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	1.8 - 4.5
Industry	Biotechnology
Sector	Healthcare
CEO	Mr. James F. Oliviero III, C.F.A., CFA
Website	https://www.checkpointtx.com

An error occurred while fetching data.

About Checkpoint Therapeutics, Inc.

Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to programmed death ligand-1 (PD-L1) and blocks